Cambridge CLDC Testing
Characteristic Leucocyte
Different Count
Click here for Excerpt from a paper “Model for rapid reduction of R (reproduction number) to below 1” written by Dr. Mark Baker
Differential
Leucocyte count
and AI Analysis
-
The CLDC (Characteristic Leucocyte Different Count) test uses easily accessible data from a full blood cell count. Providing results by analyzing the total number of leucocytes as well as the specific types of leucocyte CLDC.
-
It is possible to detect the positive results before the patient shows symptoms based on the ratio difference of blood cells in positive and negative patients.
-
This can detect the presence or absence of infection up to 2 weeks earlier than the results show through PCR tests.
Features of
CLDC testing
-
Inexpensive
-
High Accuracy (98.67%)
-
Immediate response to results (15 ~ 20min)
-
Possibility to early detection of SARS-CoV2 (Up to 2weeks earlier than PCR)
Dealing with other viral pathogens
-
The CLDC can be used for SARS CoV 2 and can be applied to certain other infections and diseases. (At present, 20 other viral pathogens)
-
By updating the collected data, the CLDC test can be used for future pathogens.
-
It is expected that the CLDC test can be used not only for pathogens, but for numerous health conditions such as diabetes, liver functions, urinalysis, PH, and ketone analysis.